Human Chorionic Gonadotropin (HCG) peptide is a heterodimeric glycoprotein extensively evaluated in preclinical research for its high-affinity interaction with the luteinizing hormone/choriogonadotropin receptor (LHCGR). Supplied strictly as a research-grade reference material for in vitro and laboratory assays, this compound allows researchers to investigate steroidogenic pathways, cellular signaling cascades, and gonadotropin receptor dynamics.
Human Chorionic Gonadotropin (HCG) peptide is a heterodimeric glycoprotein extensively evaluated in preclinical research for its high-affinity interaction with the luteinizing hormone/choriogonadotropin receptor (LHCGR). Supplied strictly as a research-grade reference material for in vitro and laboratory assays, this compound allows researchers to investigate steroidogenic pathways, cellular signaling cascades, and gonadotropin receptor dynamics.
An HCG peptid (Human Chorionic Gonadotropin peptide) is a complex heterodimeric glycoprotein compound consisting of an alpha subunit identical to pituitary gonadotropins and a unique beta subunit that determines its biological specificity. In laboratory research, it functions as a potent agonist of the luteinizing hormone/choriogonadotropin receptor (LHCGR), stimulating cyclic adenosine monophosphate (cAMP)-dependent steroidogenic pathways in cell cultures and preclinical animal models.
Structurally, the alpha subunit comprises 92 amino acids shared with luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH). The distinct beta subunit consists of 145 amino acid residues, including an elongated carboxyl-terminal peptide (CTP) rich in O-linked oligosaccharides. This extensive glycosylation alters the tertiary confirmation and extends the circulating biological half-life of the protein relative to pituitary LH, making research-grade HCG peptid an invaluable model for sustained gonadotropin receptor activation studies.
In analytical biochemistry, synthesized or isolated HCG peptid preparations require rigorous characterization. Because glycoprotein tertiary structure and post-translational modifications dictate receptor binding kinetics, researchers utilizing our complete catalog of research peptides rely on detailed mass spectrometry and chromatography profiles to confirm molecular weight (~36.7 kDa) and structural fidelity prior to quantitative assays.
The primary mechanism of HCG peptid centers on its selective binding to the G-protein coupled luteinizing hormone/choriogonadotropin receptor (LHCGR). Upon ligand binding to the extracellular domain of LHCGR, a conformational change activates heterotrimeric G-proteins (primarily Gs), which subsequently stimulates membrane-bound adenylyl cyclase.
This enzymatic activation converts intracellular ATP into cyclic AMP (cAMP), triggering downstream protein kinase A (PKA) signaling cascades. In vitro assays demonstrate that PKA phosphorylation regulates nuclear transcription factors such as steroidogenic acute regulatory protein (StAR), facilitating the transport of cholesterol across the inner mitochondrial membrane—the rate-limiting step in steroid hormone biosynthesis.
In addition to the classical Gs/cAMP/PKA pathway, high-concentration HCG peptid exposure in cell culture models has been observed to recruit the Gq/11 signaling axis, leading to phospholipase C (PLC) activation, inositol trisphosphate (IP3) generation, and intracellular calcium mobilization. Investigating these dual signaling modalities assists researchers in elucidating differential receptor trafficking and desensitization patterns.
Preclinical studies suggest that exposure to HCG peptid modulates gene expression profiles governing steroidogenesis in rodent testicular Leydig cells and ovarian granulosa cells. In murine models, administration of research-grade HCG induces marked upregulation of cytochrome P450 side-chain cleavage enzyme (CYP11A1) and 17β-hydroxysteroid dehydrogenase (17β-HSD), driving downstream testosterone and estrogen synthesis pathways.
In vitro data indicate that HCG peptid also plays a role in extracellular matrix remodeling and cell survival signaling. Cultured Leydig cell lines treated with nanomolar concentrations of HCG exhibit elevated phosphorylation of Akt (protein kinase B) and ERK1/2 mitogen-activated protein kinases, which suppress apoptotic markers and promote cellular longevity under stress conditions.
Furthermore, comparative preclinical trials evaluated in the broader PX1 research repository demonstrate how continuous versus pulsatile exposure to LHCGR agonists influences receptor down-regulation and endocytosis. Prolonged elevated exposure in laboratory setups typically induces LHCGR internalisation and temporary receptor refractory periods, providing a controlled model for studying receptor desensitization.
To properly contextualize HCG peptid within neuroendocrine research, investigators frequently compare its receptor affinity and terminal half-life against hypothalamic secretagogues and upstream gonadotropins. While HCG acts directly on peripheral target receptors (LHCGR), upstream peptides modulate pituitary release mechanisms.
In experimental models, short-chain peptide agonists such as Gonadorelin and potent analogs like Triptorelin act directly on the GnRH receptor in the anterior pituitary to induce endogenous LH and FSH secretion. Conversely, upstream modulators like Kisspeptin-10 act at the hypothalamic level to regulate GnRH pulse generation. HCG peptid bypasses both the hypothalamus and pituitary, directly engaging the peripheral receptor downstream.
Because HCG possesses an elongated half-life compared to native LH (~24–36 hours in rodent plasma vs. ~20 minutes for LH), it serves as a preferred experimental tool when stable, prolonged receptor activation is required without the necessity of frequent pulse-infusion protocols.
Maintaining structural stability of lyophylized HCG peptid requires strict adherence to physical and thermal handling protocols. Lyophilized cake should be stored in deep-freeze environments (-20°C to -80°C) protected from light until reconstitution. Exposure to moisture or ambient temperature prior to reconstitution can lead to premature peptide degradation or aggregation.
For laboratory reconstitution, researchers typically employ sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on assay compatibility. The diluent must be introduced gently down the inner glass wall of the vial, allowing the lyophilized powder to dissolve naturally without vigorous mechanical agitation. Shaking can induce shear stress, causing denaturation of the delicate heterodimeric quaternary structure.
Once reconstituted, aliquots should be stored at 2°C to 8°C for short-term experimental series (typically up to 28 days depending on diluent preservation) or frozen in single-use working volumes to avoid repeated freeze-thaw cycles, which degrade protein integrity.
In vitro and preclinical research accuracy demands rigorous purity verification. PX1 Research subjects every batch of HCG peptid to dual-stage analytical validation using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
RP-HPLC establishes chemical purity by separating the primary heterodimer from synthesis precursors, truncated peptides, and oxidation products, confirming a purity threshold exceeding 98.0%. ESI-MS verifies the exact molecular weight and subunit composition, confirming correct primary sequence and glycosylation profiles.
Critical for cell culture and preclinical animal models, endotoxin quantification is executed via Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing. PX1 Research guarantees endotoxin levels well below industry thresholds (<0.01 EU/mg), ensuring that experimental observations stem solely from HCG peptide signaling rather than inflammatory lipopolysaccharide contamination.
When designing in vitro experiments using HCG peptid, precise concentration curves and incubation timepoints are essential. Researchers investigating cAMP induction typically utilize dose-response ranges from 1 pM to 100 nM, measuring intracellular cAMP accumulation within 30 to 60 minutes of exposure using homogenous time-resolved fluorescence (HTRF) or ELISA assays.
For long-term transcriptomic studies measuring steroidogenic enzyme upregulation, exposure times range from 6 to 24 hours in serum-starved media to avoid baseline interference from serum-borne hormones. Control wells receiving non-stimulated vehicle media or non-binding peptide controls, such as CJC-1295 No DAC, are routinely incorporated to validate receptor-specific gene expression responses.
Researchers conducting high-throughput screening or multi-well plate assays can coordinate large-batch reagent sourcing through our dedicated wholesale institutional accounts to maintain consistent lot integrity across multi-phase projects.
PX1 Research operates strictly as a USA-based supplier of high-purity laboratory research chemicals. Every lot of HCG peptid is synthesized in cGMP-compliant facilities and thoroughly tested in ISO 17025 accredited analytical laboratories.
We maintain transparent quality control by providing accessible third-party Certificates of Analysis (COA) matching exact vial lot numbers. Each COA provides complete chromatographic data, mass spectra, physical appearance verifications, and endotoxin assay outcomes.
To ensure rapid reagent availability and prevent degradation during transit, orders are dispatched same-day (Monday through Friday) from our domestic logistics hubs located in California and Arizona. Products are packaged under climate-controlled conditions designed to preserve peptide bioactivity from our facilities directly to your benchtop.
What is the target receptor for HCG peptid in preclinical models?
HCG peptid targets the luteinizing hormone/choriogonadotropin receptor (LHCGR), a G-protein coupled receptor expressed primarily in testicular Leydig cells and ovarian granulosa cells.
How does HCG peptid differ from native Luteinizing Hormone (LH)?
While both peptides share an identical alpha subunit and bind to the same receptor (LHCGR), HCG features a unique 145-amino acid beta subunit with additional carboxyl-terminal glycosylation, resulting in a significantly longer biological half-life.
What analytical methods verify the purity of PX1 Research HCG peptid?
Every lot is verified using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination (>98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight confirmation.
What are the recommended storage conditions for lyophilized HCG peptid?
Lyophilized HCG peptid should be stored at -20°C or colder in a dry, dark environment. Upon arrival, vials should remain sealed until ready for reconstitution.
How should HCG peptid be reconstituted for laboratory assays?
Reconstitute using sterile Bacteriostatic Water or 0.9% Sodium Chloride by directing the solvent along the glass inner wall. Avoid vigorous shaking to prevent protein denaturation; gently swirl until fully dissolved.
What is the endotoxin limit for PX1 Research compounds?
PX1 Research compounds undergo Chromogenic LAL testing to ensure endotoxin content remains strictly below <0.01 EU/mg, minimizing inflammatory artifacts in cell culture models.
Can HCG peptid be used in research alongside GnRH agonists?
Yes. Researchers often compare direct peripheral receptor agonists like HCG peptid against hypothalamic/pituitary peptides like Gonadorelin or Triptorelin to isolate downstream signal transduction from central feedback loops.
Are PX1 Research products intended for human or veterinary administration?
No. All products sold by PX1 Research are intended strictly for in vitro laboratory research, analytical calibration, and preclinical experimental assays. Human or clinical use is strictly prohibited.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.